Related Experiment Video
Updated: May 4, 2026

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Multiple facial neoplasms in a pediatric patient during treatment for B-lymphoblastic leukemia/lymphoma
Tristan Strickland1, Madeline Conlon2, Jesse Fike2
1Joe R. & Teresa Lozano Long School of Medicine, UT Health San Antonio, San Antonio, Texas, USA.
Abstract:
Histiocytoses encompass a group of rare mononuclear phagocytic cell proliferations with diverse presentations and overlapping features, making them at times difficult to classify. We present a unique case of one such histiocytic disorder, juvenile xanthogranuloma (JXG), in a 15-year-old patient who developed lesions shortly after initiation of chemotherapy for treatment of B-lymphoblastic leukemia/lymphoma and displayed genetic mutations not typically associated with JXG. Appropriate diagnosis and management of JXG requires an understanding of key features in clinical presentation and histopathology, associated conditions, and genetic mutations.

